medigraphic.com
ISSN 2078-7170 (Electronic)

2021, Number 4

<< Back Next >>

CorSalud 2021; 13 (4)

Gender differences in the clinical and therapeutic profile of patients with atrial fibrillation

Leal BE, Domínguez BS, Arjona RIA, Quiñones MIR, Massip NJ, Fernández-Massip H, Goberna RM, Rodríguez MFD, Borges HA, Pulido IM, Valdés MEY, Cabrera RI, Enrique VSJ

Language: Spanish
References: 27
Page: 436-444
PDF size: 284.93 Kb.


ABSTRACT

Introduction: There are gender-specific differences in the epidemiology, patho-physiology, clinical presentation, treatment and outcome of atrial fibrillation. Their identification can have a major impact on the planning of screening campaigns and their treatment approaches.
Objective: To identify the gender differences in the clinical and therapeutic profile of patients with atrial fibrillation.
Method: A cross-sectional descriptive study was conducted in a sample of 146 patients at the Department of Cardiology of the Hospital Universitario General Calixto García in Havana, Cuba, from January 2014 to December 2017.
Results: Female sex (65.1%), age group 70-79 years (43.1%), hypertension in both genders (women 76.8% and men 60.8%; p=0.814), obesity (64.2 vs. 33.3%; p=0.07) and diabetes mellitus (52.6 vs. 21.6%; p=0.02) predominated. Women were more symptomatic and had a faster ventricular rate. The main associated disease in them was heart failure with preserved left ventricular ejection fraction (11.6 vs. 7.8%; p= 0.05) as unstable angina and infarction were more frequent in men. Wom-en received less oral anticoagulation (58.9 vs. 68.6%; p=0.013).
Conclusions: Differences in the clinical profile between men and women with atrial fibrillation were observed, as well as suboptimal use of oral anticoagulation in general, with significant intersex difference.


REFERENCES

  1. Rogers PA, Bernard ML, Madias C, Thihalolipa-van S, Mark Estes NA, Morin DP. Current Evi-dence-Based Understanding of the Epidemiology, Prevention, and Treatment of Atrial Fibrillation. Curr Probl Cardiol. 2018;43(6):241-83. [DOI]

  2. January CT, Wann LS, Calkins H, Chen LY, Cigar-roa JE, Cleveland JC, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American Col-lege of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(1):104-32. [DOI]

  3. O'Neal WT, Nazarian S, Alonso A, Heckbert SR, Vaccarino V, Soliman EZ. Sex hormones and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA). Endocrine. 2017;58(1): 91-6. [DOI]

  4. Pothineni NV, Vallurupalli S. Gender and Atrial Fibrillation: Differences and Disparities. US Car-diol Rev. 2018;12(2):103-6. [DOI]

  5. Gillis AM. Atrial Fibrillation and Ventricular Ar-rhythmias: Sex Differences in Electrophysiology, Epidemiology, Clinical Presentation, and Clinical Outcomes. Circulation. 2017;135(6):593-608. [DOI]

  6. Piccini JP, Hammill BG, Sinner MF, Jensen PN, Hernandez AF, Heckbert SR, et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes. 2012;5(1): 85-93. [DOI]

  7. Friberg J, Scharling H, Gadsbøll N, Jensen GB. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). Am J Cardiol. 2003;92(12):1419-23. [DOI]

  8. Bernal O, Moro C. Arritmias cardiacas en la mu-jer. Rev Esp Cardiol. 2006;59(6):609-18. [DOI]

  9. Odening KE, Deiß S, Dilling-Boer D, Didenko M, Eriksson U, Nedios S, et al. Mechanisms of sexdifferences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling. Europace. 2019;21(3): 366-76. [DOI]

  10. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019; 139(10):e56-e528. [DOI]

  11. Ganesan AN, Chew DP, Hartshorne T, Selvana-yagam JB, Aylward PE, Sanders P, et al. The im-pact of atrial fibrillation type on the risk of throm-boembolism, mortality, and bleeding: a systemat-ic review and meta-analysis. Eur Heart J. 2016; 37(20):1591-602. [DOI]

  12. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Soci-ety of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-57. [DOI]

  13. Pérez Caballero MD, León Álvarez JL, Dueñas Herrera A, Alfonzo Guerra JP, Navarro Despaigne DA, de la Noval García R, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hiper-tensión arterial. Rev Cubana Med [Internet]. 2017 [citado 2 Ago 2020];56(4):242-321. Disponible en: http://scielo. sld. cu/pdf/med/v56n4/med01417. pdf

  14. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, et al. 50 year trends in atrial fi-brillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A co-hort study. Lancet. 2015;386(9989):154-62. [DOI]

  15. Magnani JW, Norby FL, Agarwal SK, Soliman EZ, Chen LY, Loehr LR, et al. Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Com-munities (ARIC) Study. JAMA Cardiol. 2016;1(4): 433-41. [DOI]

  16. Michniewicz E, Mlodawska E, Lopatowska P, To-maszuk-Kazberuk A, Malyszko J. Patients with atrial fibrillation and coronary artery disease - Double trouble. Adv Med Sci. 2018;63(1):30-5. [DOI]

  17. Pouwels S, Topal B, Knook MT, Celik A, Sundbom M, Ribeiro R, et al. Interaction of obesity and atri-al fibrillation: an overview of pathophysiology and clinical management. Expert Rev Cardiovasc Ther. 2019;17(3):209-23. [DOI]

  18. Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159-69. [DOI]

  19. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabe-tes Mellitus: Atherosclerotic Cardiovascular Dis-ease and Heart Failure in Type 2 Diabetes Melli-tus - Mechanisms, Management, and Clinical Con-siderations. Circulation. 2016;133(24):2459-502. [DOI]

  20. Sandín M, Espelt A, Escolar-Pujolar A, Arriola L, Larrañaga I. Desigualdades de género y diabetes mellitus tipo 2: La importancia de la diferencia. Av Diabetología. 2011;27(3):78-87. [DOI]

  21. Jankowska-Polańska B, Kaczan A, Lomper K, No-wakowski D, Dudek K. Symptoms, acceptance of illness and health-related quality of life in patients with atrial fibrillation. Eur J Cardiovasc Nurs. 2018;17(3):262-72. [DOI]

  22. Gómez Doblas JJ, Muñiz J, Alonso Martín JJ, Ro-driguez-Roca G, Lobos JM, Awamleh P, et al. Pre-valencia de fibrilación auricular en España. Re-sultados del Estudio OFRECE. Rev Esp Cardiol. 2014;67(4):259-69. [DOI]

  23. Cherian TS, Shrader P, Fonarow GC, Allen LA, Piccini JP, Peterson ED, et al. Effect of Atrial Fi-brillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treat-ment of Atrial Fibrillation [ORBIT-AF]). Am J Car-diol. 2017;119(11):1763-9. [DOI]

  24. Su CH, Tsao TF, Chen AC, Chang KW, Yang YS, Ueng KC, et al. CHA2DS2-VASc scores for outcome prediction in acute ischaemic stroke. Eur J Clin Invest [Internet]. 2018 [citado 1 Ago 2020];48(3): e12884. Disponible en:https://doi. org/10. 1111/eci. 12884

  25. McIntyre WF, Conen D, Olshansky B, Halperin JL, Hayek E, Huisman MV, et al. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program. Clin Cardiol. 2018;41(6):744-51. [DOI]

  26. Silberberg A, Tan MK, Yan AT, Angaran P, Dorian P, Bucci C, et al. Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Out-patients With Atrial Fibrillation: From the Facili-tating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF). Am J Car-diol. 2017;120(4):582-7. [DOI]

  27. Shehab A, Zubaid M, Bhagavathula AS, Rashed WA, Alsheikh-Ali AA, AlMahmeed W, et al. Sex differences in management and outcomes of pa-tients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events (Gulf SAFE). PLoS One [Internet]. 2017 [citado 7 Ago 2020];12(5):e0175405. Disponible en:https://doi. org/10. 1371/journal. pone. 0175405




2020     |     www.medigraphic.com